Phospho-ERK1/2 (Thr202/Tyr204) Polyklonaler Antikörper

Phospho-ERK1/2 (Thr202/Tyr204) Polyklonal Antikörper für IP, WB, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus, Ratte und mehr (2)

Anwendung

WB, IP, IHC, IF, ELISA

Konjugation

Unkonjugiert

Publikationen

254

Rezensionen (2)

Kat-Nr. : 28733-1-AP

Synonyme

ERK 1, ERK1, ERK1/2, ERT2, HS44KDAP, HUMKER1A, Insulin stimulated MAP2 kinase, MAP kinase 1, MAP kinase 3, MAP kinase isoform p44, MAPK 1, MAPK 3, MAPK3, p44 ERK1, p44 MAPK, P44ERK1, P44MAPK, Phospho-ERK1/2 (Thr202/Tyr204), PRKM3

---

Galerie der Validierungsdaten

• 

  WB analysis using 28733-1-AP

  Non-treated and Calyculin A treated PC-3 cells were subjected to SDS PAGE followed by western blot with 28733-1-AP (Phospho-ERK1/2 (Thr202/Tyr204) antibody) at dilution of 1:4500 incubated at 4℃ overnight.

• 

  WB analysis using 28733-1-AP

  Non-treated HEK-293T and Calyculin A treated HEK-293T cells were subjected to SDS PAGE followed by western blot with 28733-1-AP (ERK1/2-phospho-Thr202/Tyr204) at dilution of 1:3000 incubated at 4℃ overnight. The membrane was stripped and re-blotted with GAPDH antibody as loading control.

• 

  IP experiment of PC-3 using 28733-1-AP

  IP result of anti-Phospho-ERK1/2 (Thr202/Tyr204)(IP:28733-1-AP, 2ug; Detection:28733-1-AP 1:1000) with Calyculin A treated PC-3 cells lysate 1552 ug.

---

Geprüfte Anwendungen

• Erfolgreiche Detektion in WB: Mit Calyculin A behandelte PC-3-Zellen, mit Calyculin A behandelte HEK-293T-Zellen
• Erfolgreiche IP: Mit Calyculin A behandelte PC-3-Zellen

Empfohlene Verdünnung

• Western Blot (WB): WB : 1:1000-1:9000
• Immunpräzipitation (IP): IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Veröffentlichte Anwendungen

• KD/KO: See 1 publications below
• WB: See 249 publications below
• IHC: See 14 publications below
• IF: See 6 publications below

Produktinformation

28733-1-AP bindet in WB, IP, IHC, IF, ELISA Phospho-ERK1/2 (Thr202/Tyr204) und zeigt Reaktivität mit human, Maus, Ratten

• Getestete Reaktivität: human, Maus, Ratte
• In Publikationen genannte Reaktivität: human, Hausschwein, Huhn, Maus, Ratte
• Wirt / Isotyp: Kaninchen / IgG
• Klonalität: Polyklonal
• Typ: Antikörper
• Immunogen: Peptid
• Vollständiger Name: mitogen-activated protein kinase 3
• Berechnetes Molekulargewicht: 38-43 kDa
• Beobachtetes Molekulargewicht: 38-43 kDa
• GenBank-Zugangsnummer: NM_002746
• Gene symbol: MAPK3
• Gene ID (NCBI): 5595
• Konjugation: Unkonjugiert
• Form: Liquid
• Reinigungsmethode: Antigen-Affinitätsreinigung
• Lagerungspuffer: PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3.
• Lagerungsbedingungen: Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20^oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, cytoskeletal rearrangements. The MAPK/ERK cascade plays also a role in initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors. MEK1 and MEK2 activate p44 and p42 through phosphorylation of activation loop residues Thr202/Tyr204 and Thr185/Tyr187, respectively. Several downstream targets of p44/42 have been identified, including p90RSK and the transcription factor Elk-1. The antibody recognizes ERK2 phosphorylation sites Thr185 and Tyr187.

Publikationen

Species	Application	Title
human	WB	Mol Cancer; Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression.; Authors - Zhenzhen Pan
mouse	WB	J Nanobiotechnology; Peptide-anchored neutrophil membrane-coated biomimetic nanodrug for targeted treatment of rheumatoid arthritis; Authors - Ni Yang
human	WB	Proc Natl Acad Sci U S A; Progesterone activates GPR126 to promote breast cancer development via the Gi pathway.; Authors - Wentao An
human	WB,IHC	Int J Biol Sci; FLOT1 promotes gastric cancer progression and metastasis through BCAR1/ERK signaling; Authors - Ran Wang
mouse	WB	J Hazard Mater; Prenatal exposure to environmentally relevant levels of PBDE-99 leads to testicular dysgenesis with steroidogenesis disorders.; Authors - Tianxin Zhao
mouse,human	WB	Cell Rep; Targeting CXCR1 alleviates hyperoxia-induced lung injury through promoting glutamine metabolism; Authors - Hao Qin

Rezensionen

The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.

---

FH

Alexandra (Verified Customer) (06-06-2023)

P19 cells were aggregated in bacteria petri dishes for 6h (point1) and 12 and 24 h (point 2 and 3) in the presence of 1uM RA (retinoic acid). For neuronal differentiation the RA treatment lasts for 4 days, the cells are trypsinized and cultured in serum free neurobasal medium supplemented with N2, glutamax and penstrep. Cell aggregates were collected by centrifugation, washed in 1X PBS and lysed in denaturing lysis buffer. For WB i used PVDF, blocking in 5%milk and the antibody incubation was O/N at 4C. Please do not include the Parp1 KO annotation if you will use this data. In the PDF you can find the ladder and the exposition as well. If the data did not get uploaded (i cannot tell) let me know and i will send it by email.

• Applications: Western Blot
• Primary Antibody Dilution: 1:3000
• Cell Tissue Type: P19 derived embryonic bodies

FH

Macarena Lucia (Verified Customer) (10-17-2022)

nice band

• Applications: Western Blot
• Primary Antibody Dilution: 1:1000